NAADAC and Hazelden partner to improve treatment for co-occurring disorders

NAADAC, the Association for Addiction Professionals, and Hazelden, the national nonprofit focused on addiction treatment, prevention and recovery announced today a new strategic partnership focused on improving the treatment of co-occurring disorders. The partnership announcement was made by NAADAC Executive Director Cynthia Moreno Tuohy during the National Conference on Addiction Disorders in Washington, D.C.

"The new Hazelden/NAADAC affiliation will provide NAADAC members, psychiatrists, psychologists and other counselors with collaborative in-person training and distance learning in the integrated treatment of co-occurring disorders," said Hazelden President and CEO Mark G. Mishek. The partnership will kick off in September with the national launch of the new NAADAC/Hazelden Lifelong Training Program, Integrating Treatment for Co-Occurring Disorders: An Introduction to What Every Addiction Counselor Needs to Know.

"Thousands of people in need of addiction treatment services in the U.S. also have mental health or medical issues such as depression, post-traumatic stress syndrome and bi-polar disorders," says NAADAC's Cynthia Moreno Tuohy. "In fact, the Substance Abuse and Mental Health Services Administration (SAMHSA) estimates that fully half of Americans with mental illness also abuse illicit drugs or alcohol. Hazelden and NAADAC have worked together for years to train clinicians and administrators in the addiction profession and to advocate for addiction treatment. This new partnership will be the most cohesive effort yet from Hazelden and NAADAC to promote excellence in the field of diagnosing and treating co-occurring disorders."

Hazelden and NAADAC will also feature other training opportunities and print publications on each organization's Website, making them more easily accessible to professionals. In addition, NAADAC and Hazelden will also co-sponsor Web conferences on the integrated treatment of co-occurring disorders.

SOURCE Hazelden Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive CAD 45 million to study new psychosis treatments